Urinary Diversion After Cystectomy for Bladder Cancer @oncoalert.bsky.social @jama.com doi:10.1001/jamaoncol.2025.3644

What is the ovarian cancer? @jama.com @oncoalert.bsky.social

Biz doktor değiliz sadece. Birine iyi gelme niyeti taşıyan insanlarız…

ASCO LDP is One of ASCO’s Best - Yüksel Ürün @yukselurun.bsky.social @ascocancer.bsky.social oncodaily.com/voices/asco-... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

ASCO LDP is one of ASCO’s best. Happy and proud to be part of it. Leadership in cancer care is not status, it is service. We grow when we listen, advocate, and walk with others. @ascocancer.bsky.social @oncoalert.bsky.social

Some illnesses touch the body, some touch the quiet place in the soul. Healing often begins there…

The best technology in cancer care is empathy. Without it, even perfect data feels cold…

Truth grows where doubt has space…

We talk about survival, Patients talk about life. We must learn patients’ language…

When we treat the disease, we help. When we treat the person, we heal.

📍2025-2029 ISLB President @UmbertoMalapel1 and Vice President @ElJanLe in the Closing Ceremony - Orlando Congress. A lot of work to do to prepare educational activities, workshops, guidelines and our next congress in Madrid 2026. @christianrolfo.bsky.social @islb.info @yukselurun.bsky.social

Three Words, One Mission - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Ivonescimab + Chemo Improves PFS in 1L sq-NSCLC - Yüksel Ürün @yukselurun.bsky.social @erikahamilton9.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Global Cancer Burden Calls for Action on Prevention and Equity - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Proud to join such inspiring colleagues as an #ESMOAmbassadors Excited for #ESMO25 and all the new #CancerResearch ahead. @myesmo.bsky.social

@ptarantinomd.bsky.social ; @yukselurun.bsky.social ; @arndtvogel.bsky.social ; @tiansterzhangmd.bsky.social

Hastalarımıza gerçeği anlatmak. Ne korku satmak, ne de sahte umut vermek. Medya, veriyi dürüst anlattığında güç katar. Ama çarpıtılmış grafikler, abartılmış başlıklar, seçilmiş veriler… Korku yaratır. Umudu kirletir. Gerçeği savunmak, hastalarımızı korumaktır. Veri konuşsun, biz dinleyelim.

Cancer care often forgets those at the edges: teens, elders, people with rare cancers. Their needs don’t fit the standard path. Fertility, intimacy, body image deserve the same care as the tumor. @oncoalert.bsky.social @oncoassist.bsky.social

Every patient is first a human being with a name, a story, a dream. Dignity is part of the treatment. Never reduce a life to a diagnosis… @ascocancer.bsky.social @myesmo.bsky.social @oncoalert.bsky.social

Proud of our rising star Coşkun and all colleagues. This meta-analysis on PARP inhibitors and thrombosis risk asks the right question for patients. @oncoalert.bsky.social @myesmo.bsky.social @apccc.bsky.social @drchoueiri.bsky.social @neerajagarwal.bsky.social

“Medice, cura te ipsum” Doctor, heal yourself. Even healers burn out. Rest is not weakness, it is repair. Caring for others starts with caring for yourself. @oncoalert.bsky.social @oncbrothers.bsky.social @ascocancer.bsky.social @myesmo.bsky.social

Dr. Yüksel Ürün’s Highlights from VIRO 2025 on Personalizing Treatment in the Frontline Setting @yukselurun.bsky.social oncodaily.com/pulse/dr-yuk... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #VIRO #VIRO25

Join Us for Global Voices in Renal Oncology Virtual Congress 2025 @yukselurun.bsky.social oncodaily.com/pulse/global... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Global voices, shared hope. Excited to join colleagues at VIRO 2025—working together for patients in renal cancer. #OncoDaily #VIRO2025 @oncodaily.bsky.social docs.google.com/forms/d/e/1F...

🌍 𝗚𝗹𝗼𝗯𝗮𝗹 𝗩𝗼𝗶𝗰𝗲𝘀 𝗶𝗻 𝗥𝗲𝗻𝗮𝗹 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 (𝗩𝗜𝗥𝗢) 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 📅 Sept 11–12, 2025 | 🩺 Chaired by Dr. Rana McKay & co-chaired by Dr. Yüksel Ürün @yukselurun.bsky.social 🔗 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲: forms.gle/qcQyaGMQfHDh... oncodaily.com/pulse/rana-m... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd

Meet the Experts of VIRO 2025 - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/pulse/yuksel... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Liquid Biopsy Is No Longer the Future - Yüksel Ürün @yukselurun.bsky.social @neerajagarwal.bsky.social @euplatinum.bsky.social oncodaily.com/science/liqu... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LiquidBiopsy

Cancer Prevention is the Quiet Revolution - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/voices/yukse... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Every patient teaches me something new about strength, hope, and why we fight.

Science Is Better When It’s Shared - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/blog/science... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Science

Breast Cancer Care Shouldn’t Be a Luxury - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/insight/yuks... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #BreastCancer

This sounds like an exciting step forward! How soon do you think cancer vaccines like these could become more widely used?

A Promising Option for Non–Non-Clear-Cell Renal Cell Carcinoma - Yüksel Ürün @yukselurun.bsky.social @euplatinum.bsky.social oncodaily.com/science/yuks... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #nccRCC #KidneyCancer

How Should We Treat mCRPC and HRR Deficiency? - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/blog/how-sho... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #mCRPC #HRR #ProstateCancer

First Positive Phase 3 Trial for a Bispecific ADC - Paolo Tarantino @ptarantinomd.bsky.social @yukselurun.bsky.social oncodaily.com/insight/paol... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADC

Cancer vaccines: the next frontier is now. From HBV & HPV to personalized mRNA shots @oncoalert.bsky.social @oncoassist.bsky.social @ptarantinomd.bsky.social @drchoueiri.bsky.social @viveksubbiah.bsky.social

Take care of your kidneys, protect your life. 4 simple actions = less risk, better outcomes: 🚭 Quit smoking ⚖️ Stay at a healthy weight 🏃‍♀️ Be active, avoid trauma 💧 Drink water, skip alcohol Because prevention is power @oncoalert.bsky.social @drchoueiri.bsky.social @kidneycan.bsky.social

🎗 Gerçek bilim bazen zor konuşur. Herkes “mucize” ister, ama biz sabırla örülmüş gerçekleri anlatırız. 📌 Evet, süreç yorucu. 📌 Evet, sonuç her zaman adil değil. Ama geçmişe göre çok daha iyiyiz. Birçok tümörde, yıllar kazandıran tedaviler var artık

Bugünkü kelimemiz: Radikal Prostatektomi 🧬 Prostat kanseri tedavisinde sık kullanılan bu kelime, aslında ne demek? 👨‍⚕️ Prostat bezinin tamamen çıkarıldığı bir ameliyat. Genellikle erken evredeki hastalarda uygulanır. 🎯 Bilmek güç verir. Takipte kalın, diğer terimleri de birlikte öğrenelim.

🔬 Klinik Araştırma Nedir? Kanser gibi ciddi hastalıklar için daha etkili, daha güvenli tedaviler geliştirmek amacıyla yürütülen bilimsel çalışmalardır. Her klinik araştırma; hem bugünün hastalarına yeni bir tedavi seçeneği sunar, hem de gelecekte binlerce hayatın değişmesine katkı sağlar. #science

Biyopsi = Şüpheli dokudan parça alıp mikroskopla incelemek. Örneğin: “Mesanedeki kitlenin ne olduğunu anlamak için biyopsi yapıldı.” 🎯 Çünkü doğru tanı, doğru tedavinin ilk adımıdır.

I have two favourite studies from #ASCO25 @christielibrary.bsky.social @mcrcnews.bsky.social 👇🏽 www.nejm.org/doi/full/10....

Our new JAMA Cardiology study finds that many US adults don't know that they have hypertension, diabetes, or high cholesterol Nearly 1 in 3 young adults w/ hypertension, 2 in 5 with diabetes, and 1 in 4 with high cholesterol are unaware of their condition. bit.ly/45an6MC #medsky #cardiosky

#ASMS2025 ThP046 come to check out Jenny’s poster! Don’t miss this great opportunity to meet Jenny! @asms.org @jyates.bsky.social @femalesinms.bsky.social #teammassspec @garcialabms.bsky.social @proteomicsnews.bsky.social

This is so true. We have to continually work together to get better #healthcare delivery & #research advances to ALL #patients.

Every oncologist is a patient advocate. Right treatment. Right time. For every patient. #ASCO25 #Oncology #CancerCare #AccessMatters @oncoalert.bsky.social @ascocancer.bsky.social @viveksubbiah.bsky.social @ptarantinomd.bsky.social @oncbrothers.bsky.social

Thrilled to share our new analysis from CheckMate 901! 🟡In N+ only metastatic UC, Nivolumab + chemo doubled complete response rate vs chemo alone (63% vs 34%) and prolonged PFS and OS. ➡️A new horizon for a distinct subgroup. @uroweb.org @oncoalert.bsky.social @oncbrothers.bsky.social

📢 Just in: Multivitamins after MI in diabetes? 🔬 In this RCT (n=1000), oral multivitamins didn't reduce CV events after MI in patients with diabetes. 🎯 35% event rate in both arms HR: 0.99 No benefit. #Cardiology #Diabetes #RCT #JAMA

Longitudinal ctDNA profiling in mCRPC reveals how Tumors evolve - Yüksel Ürün @yukselurun.bsky.social oncodaily.com/science/yuks... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ctDNA #mCRPC #ProstateCancer

New era for HER2-mutant lung cancer! Zongertinib delivered a 71% response rate, 12.4 months median PFS! No ILD reported. Precision hitting its mark! #LungCancer #Oncology #Targeted #cancerresearch @nejm.org @oncoalert.bsky.social @viveksubbiah.bsky.social @ptarantinomd.bsky.social